Taming menopause? Antibody might restrain obesity, osteoporosis risks

brody tmagArticle

Menopause often has some pretty negative effects on women. Their risks of heart disease, osteoporosis and obesity all increase, to say nothing of the hot flashes that can make life a misery.

A recent report in Nature provides preliminary evidence that a means of dealing with both obesity and bone loss might just be in the pipeline — an antibody that blocks receptors for the hormone FSH (follicle-stimulating hormone).

While mice don’t undergo menopause the way that women do, one can mimic the menopausal milieu by removing the rodents’ ovaries — no ovaries, no estrogen, higher levels of FSH.

The investigators produced antibodies to the mice’s FSH receptors, which would prevent the hormone from binding to those receptors and thus block whatever effects it would have in various tissues. They compared the effects of the anti FSH receptor (FSHr) antibody in normal and ovariectomized mice with those of mice treated with a different antibody (goat IgG) which would be inactive in mice.

Mice treated with antibody, when fed with normal chow, showed a reduction in body weight — their fat mass was reduced and lean body mass increased.

While a mouse is not a woman, these results imply that blocking the FSH receptor in peri- and menopausal women might be effective in blocking the accretion of visceral fat that so often accompanies menopause, as well as protecting bone.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Antibody Could Help With Post-Menopausal Issues, Mouse Study Suggests

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
ChatGPT-Image-May-1-2026-02_20_13-PM
How RFK, Jr.’s false vaccine claims are holding up $600 million to fight diseases in poor countries
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
viva-la-vida-watermelons
Misinformation and climate change are endangering summer watermelons
ChatGPT-Image-Mar-27-2026-11_27_05-AM
The myths of “process”: What science says about the “dangers’ of synthetic products and ultra-processed foods
Drinking lots of water can help reduce the effects of aging
Nanoplastics in drinking water: MAHA activists forge science-based bipartisan coalition 
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.